Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis. (TAVI QdV)

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

In order to overcome the shortcomings of the assessment questionnaires currently available on the assessment of overall quality of life, the Toronto Aortic Stenosis Quality of Life Questionnaire (TASQ) was developed as a specific assessment tool for the impact of severe aortic stenosis in elderly patients, through 16 questions covering 5 domains: symptoms and physical limitations, emotional impact and expectations following TAVI, as well as social limitations incurred. A better knowledge and understanding of the clinical outcomes and quality of life of elderly patients with severe symptomatic aortic stenosis at 12 months of follow-up of a TAVI procedure would further optimize the clinical decision-making process and patient selection who will benefit the most from this intervention in the long term.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male, female, over 18 years old,

• All patients who will have transfemoral percutaneous aortic valve replacement (TAVI) with implantation of a valve delivered on a balloon,

• Patient able to understand the study, and answer the TASQ questionnaire,

• Affiliation to a social security scheme or beneficiary of such a scheme,

• Patient having signed the free and informed consent.

Locations
Other Locations
France
Jean-François Oudet
RECRUITING
La Rochette
Contact Information
Primary
Marie-Jeanne Bertrand, Dr
mariejeanne.bertrand@gmail.com
04 38 38 04 34
Backup
Jean-François Oudet
jeanfrancois.oudet@free.fr
0683346567
Time Frame
Start Date: 2023-03-21
Estimated Completion Date: 2026-03
Participants
Target number of participants: 140
Treatments
Patient with percutaneous aortic valve replacement via the transfemoral approach
Sponsors
Leads: Elsan
Collaborators: Belledonne clinic, European Clinical Trial Experts Network

This content was sourced from clinicaltrials.gov